Guardant Health Inc.

NASDAQ: GH · Real-Time Price · USD
58.84
-1.52 (-2.52%)
At close: Aug 15, 2025, 3:59 PM
58.88
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Guardant Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
739.02M 563.95M 449.54M 373.65M
Cost of Revenue
289.8M 227.05M 156.32M 122.91M
Gross Profit
449.22M 336.9M 293.21M 250.74M
Operating Income
-443.59M -564.73M -544.38M -411M
Interest Income
53.69M 35.37M 6.07M 3.93M
Pretax Income
-435.09M -478.76M -653.45M -384.47M
Net Income
-436.37M -479.45M -654.59M -405.67M
Selling & General & Admin
545.06M 451.03M 463.78M 398.52M
Research & Development
347.75M 367.19M 373.81M 263.22M
Other Expenses
n/a 83.4M n/a n/a
Operating Expenses
892.81M 901.62M 837.59M 661.74M
Interest Expense
2.58M 2.58M 2.58M 2.58M
Selling & Marketing Expenses
364.94M 295.23M 299.83M 191.88M
Cost & Expenses
1.18B 1.13B 993.92M 784.65M
Income Tax Expense
1.28M 685K 1.14M 300K
Shares Outstanding (Basic)
122.75M 111.99M 102.18M 101.31M
Shares Outstanding (Diluted)
122.75M 111.99M 102.18M 101.31M
EPS (Basic)
-3.56 -4.28 -6.41 -3.8
EPS (Diluted)
-3.56 -4.28 -6.41 -3.8
EBITDA
-390.12M -433.31M -614.91M -359.62M
EBIT
-432.51M -476.19M -650.87M -381.89M
Depreciation & Amortization
42.39M 42.88M 35.96M 22.27M